BANK OF AMERICA CORP /DE/ - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 137 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$106,336
-13.1%
98,459
+3.8%
0.00%
Q2 2023$122,412
-44.0%
94,893
-42.7%
0.00%
Q1 2023$218,645
-21.1%
165,640
-10.4%
0.00%
Q4 2022$277,261
-22.1%
184,841
-38.9%
0.00%
Q3 2022$356,000
-72.0%
302,323
-73.1%
0.00%
Q2 2022$1,270,000
+54.5%
1,123,297
+308.3%
0.00%
Q1 2022$822,000
+24.0%
275,117
+10.1%
0.00%
Q4 2021$663,000
-39.1%
249,989
-16.7%
0.00%
Q3 2021$1,089,000
-15.5%
300,152
+1.1%
0.00%
Q2 2021$1,289,000
+71.0%
296,987
+34.8%
0.00%
Q1 2021$754,000
+719.6%
220,287
+736.2%
0.00%
Q4 2020$92,000
+7.0%
26,344
-26.4%
0.00%
Q3 2020$86,000
-28.9%
35,776
-45.9%
0.00%
Q2 2020$121,000
+55.1%
66,181
+32.5%
0.00%
Q1 2020$78,000
-44.3%
49,953
-24.0%
0.00%
Q4 2019$140,000
-28.9%
65,692
-37.8%
0.00%
Q3 2019$197,000
-68.3%
105,552
-55.6%
0.00%
Q2 2019$621,000
-77.5%
237,829
-77.9%
0.00%
Q1 2019$2,766,000
+105.3%
1,076,571
+83.7%
0.00%
Q4 2018$1,347,000
+897.8%
585,952
+1294.3%
0.00%
Q3 2018$135,000
-85.8%
42,024
-87.5%
0.00%
Q2 2018$950,000
-48.5%
335,919
-35.5%
0.00%
Q1 2018$1,844,000
+831.3%
520,794
+922.1%
0.00%
Q4 2017$198,000
+63.6%
50,952
+6.5%
0.00%
Q3 2017$121,000
+53.2%
47,820
+65.1%
0.00%
Q2 2017$79,000
-78.4%
28,973
-73.7%
0.00%
Q1 2017$365,000
-57.1%
110,277
-69.1%
0.00%
Q4 2016$850,000
+52.1%
356,901
+134.4%
0.00%
Q3 2016$559,000
+954.7%
152,251
+545.1%
0.00%
Q2 2016$53,000
+140.9%
23,600
+119.1%
0.00%
Q1 2016$22,000
-74.1%
10,770
-61.5%
0.00%
Q4 2015$85,000
+962.5%
27,985
+765.1%
0.00%
Q3 2015$8,000
-52.9%
3,235
-40.6%
0.00%
Q2 2015$17,000
+112.5%
5,446
+138.0%
0.00%
Q1 2015$8,000
+700.0%
2,288
+535.6%
0.00%
Q4 2014$1,000
-99.2%
360
-99.4%
0.00%
Q3 2014$124,000
-3.9%
63,829
+79.3%
0.00%
Q2 2014$129,0000.0%35,601
+6.8%
0.00%
Q1 2014$129,000
-67.5%
33,339
-76.1%
0.00%
Q4 2013$397,000
+84.7%
139,239
+131.9%
0.00%
Q3 2013$215,000
+26.5%
60,034
+17.9%
0.00%
Q2 2013$170,00050,9090.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,847,087$4,119,0003.26%
Sio Capital Management, LLC 1,333,696$2,974,0001.52%
Boxer Capital, LLC 700,000$1,561,0001.38%
Palo Alto Investors LP 5,386,534$12,012,0000.91%
ACUTA CAPITAL PARTNERS, LLC 747,748$1,667,0000.80%
SENZAR ASSET MANAGEMENT, LLC 1,443,003$3,217,897,0000.70%
Ghost Tree Capital, LLC 800,000$1,784,0000.52%
NEA Management Company, LLC 3,243,150$7,232,0000.38%
Rhenman & Partners Asset Management AB 850,000$1,896,0000.34%
Rock Springs Capital Management LP 1,750,000$3,903,0000.29%
View complete list of RIGEL PHARMACEUTICALS INC shareholders